Cellosaurus logo
expasy logo

Cellosaurus SNU-1196/GR (CVCL_C1L2)

[Text version]
Cell line name SNU-1196/GR
Accession CVCL_C1L2
Resource Identification Initiative To cite this cell line use: SNU-1196/GR (RRID:CVCL_C1L2)
Comments Population: Korean.
Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
Derived from site: In situ; Common hepatic duct; UBERON=UBERON_0001175.
Disease Hilar cholangiocarcinoma (NCIt: C36077)
Klatskin tumor (ORDO: Orphanet_99978)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_5015 (SNU-1196)
Sex of cell Sex unspecified
Age at sampling Age unspecified
Category Cancer cell line
Publications

PubMed=28883618; DOI=10.1038/s41598-017-11094-3; PMCID=PMC5589721
Jung D.E., Park S.B., Kim K., Kim C., Song S.Y.
CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines via miRNAs targeting the Hippo pathway.
Sci. Rep. 7:10921-10921(2017)

Cross-references
Encyclopedic resources Wikidata; Q114313037
Entry history
Entry creation22-Sep-2022
Last entry update29-Jun-2023
Version number4